Profound Medical Corp PROF

Primary Symbol: T.PRN

Healthcare Medical Devices

Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA procedure, performed using the TULSA-PRO system, has the potential of becoming a mainstream treatment modality across the entire prostate disease spectrum; ranging from low -, intermediate-, or high-risk prostate cancer; to hybrid patients suffering from both prostate cancer and benign prostatic hyperplasia (BPH); to men with BPH only; and also, to patients requiring salvage therapy for radio-recurrent localized prostate cancer. It is also commercializing Sonalleve, a therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases.

TSX:PRN - Post by User

Profound Medical Corp > CFO Aaron Davidson big seller this year in mid to high $20s

<< Previous

Bullboard Posts

Next >>

Comment by MrMugsyon May 03, 2021 5:55pm

147 Views

Post# 33120021

RE:CFO Aaron Davidson big seller this year in mid to high $20s

VerusSemperSors wrote:
I see $4,107,192 worth of PRN shares sold and none bought by insiders in last 12 months. Any idea why CFO Aaron Davison is not holding his shares?

I see it's mostly Aaron Davison.

I have seen it when a person is leaving a company ... but that doesn't seem to be the case.

I also know of a CFO from a Waterloo tech company who always cashed out his shares ... didn't seem to be interested in playing the market game. Always took as pay - in cash.

In this case, would need to ask him.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing